Atlas Trials

Nykode Therapeutics ASA

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Nykode Therapeutics ASA

RecordFirmDate
Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer. (NCT06099418)Nykode Therapeutics ASA2024-04-18
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma (NCT06016920)Nykode Therapeutics ASA2023-12-19
Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors (NCT05018273)Nykode Therapeutics ASA2021-12-21
A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers (NCT05069623)Nykode Therapeutics ASA2021-11-01
Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer (NCT04405349)Nykode Therapeutics ASA2020-07-01
A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer (NCT03548467)Nykode Therapeutics ASA2018-04-04

Track Nykode Therapeutics ASA automatically

Every clearance here is in the API, with alerts when new ones post.